UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing.
There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors associated with these disparities, and the RADx Radical (RADx-rad) program, which supports innovative approaches to addressing gaps in COVID-19 testing.
California [US], February 24 (ANI): A clinical study led by researchers of the University of California claims to help explain the wide variety of COVID-19 symptoms and aid search for therapies for the deadly infection.
UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVID-19 symptoms and aid the search for therapies.
Study explains aid to wide variety of COVID-19 sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.